Send feedback

SCN2A p.Arg1022Pro

c.3065G>C · rs376774884 · VCV1709071

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.7359 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.0011%, sas)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
seizures, benign familial infantile, 3

Computational evidence

Protein change
AlphaMissense0.7359likely pathogenic
REVEL0.662pathogenic-leaning
SaProtLLR -10.98damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.1GERP -1.5, phastCons 0.45
Regional constrainto/e 0.77unconstrained · MANE · 16 kb · p 5.9e-05 · regional, not allelic
Overall
CADD21.6PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0011% South Asian · 1/91,084 alleles
Overall 0.000137% 2/1,461,764 alleles · very rare
Ancestry group Frequency 1 in
South Asiangrpmax 0.0011% 91,084
European (non-Finnish) 8.47e-05% 1,179,960

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SCN2A
Protein
p.Arg1022Pro
Coding
c.3065G>C
MANE Select
NM_001040142
dbSNP
rs376774884
Type
single nucleotide variant
Location
chr2:165354337 (GRCh38)
Gene constraint
LOEUF 0.161 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 69.28 · 5 PDB
Residue 1022
a UniProt-annotated variant site (found in a patient with intractable epilepsy and severe mental decline; likely pathogenic; non-conducting; loss of voltage-gated sodium channel activity; dominant-negative); a UniProt-annotated variant site (found in a patient with schizofrenia; uncertain significance); a UniProt-annotated variant site (found in a patient with autism spectrum disorder; likely pathogenic); a UniProt-annotated variant site (found in a patient with autism spectrum disorder; likely pathogenic; loss of voltage-gated sodium channel activity; non-conducting)
Full SCN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

seizures, benign familial infantile, 3 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Self-limited neonatal-infantile epilepsy (Orphanet):

Inheritance
Autosomal dominant
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/scn2a-p-arg1022pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown